GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » PS Ratio

Redx Pharma (LSE:REDX) PS Ratio : 11.54 (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Redx Pharma's share price is £0.15. Redx Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01. Hence, Redx Pharma's PS Ratio for today is 11.54.

The historical rank and industry rank for Redx Pharma's PS Ratio or its related term are showing as below:

LSE:REDX' s PS Ratio Range Over the Past 10 Years
Min: 0.15   Med: 15.64   Max: 119.94
Current: 11.54

During the past 12 years, Redx Pharma's highest PS Ratio was 119.94. The lowest was 0.15. And the median was 15.64.

LSE:REDX's PS Ratio is ranked worse than
55.8% of 1000 companies
in the Biotechnology industry
Industry Median: 9.14 vs LSE:REDX: 11.54

Redx Pharma's Revenue per Sharefor the six months ended in Sep. 2023 was £0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01.

Warning Sign:

Redx Pharma PLC revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Redx Pharma was -79.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -26.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 57.10% per year.

During the past 12 years, Redx Pharma's highest 3-Year average Revenue per Share Growth Rate was 239.10% per year. The lowest was -50.30% per year. And the median was 5.05% per year.

Back to Basics: PS Ratio


Redx Pharma PS Ratio Historical Data

The historical data trend for Redx Pharma's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma PS Ratio Chart

Redx Pharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.20 17.11 21.92 8.83 20.00

Redx Pharma Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.92 - 8.83 - 20.00

Competitive Comparison of Redx Pharma's PS Ratio

For the Biotechnology subindustry, Redx Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redx Pharma's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's PS Ratio distribution charts can be found below:

* The bar in red indicates where Redx Pharma's PS Ratio falls into.



Redx Pharma PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Redx Pharma's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.15/0.013
=11.54

Redx Pharma's Share Price of today is £0.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redx Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Redx Pharma  (LSE:REDX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Redx Pharma PS Ratio Related Terms

Thank you for viewing the detailed overview of Redx Pharma's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Redx Pharma (LSE:REDX) Business Description

Traded in Other Exchanges
N/A
Address
Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines